Literature DB >> 24855188

Predicting treatment outcomes in CLL.

Adrian Wiestner1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24855188      PMCID: PMC4046433          DOI: 10.1182/blood-2014-04-565325

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

Authors:  M Hallek; K Fischer; G Fingerle-Rowson; A M Fink; R Busch; J Mayer; M Hensel; G Hopfinger; G Hess; U von Grünhagen; M Bergmann; J Catalano; P L Zinzani; F Caligaris-Cappio; J F Seymour; A Berrebi; U Jäger; B Cazin; M Trneny; A Westermann; C M Wendtner; B F Eichhorst; P Staib; A Bühler; D Winkler; T Zenz; S Böttcher; M Ritgen; M Mendila; M Kneba; H Döhner; S Stilgenbauer
Journal:  Lancet       Date:  2010-10-02       Impact factor: 79.321

2.  SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Authors:  S Jeromin; S Weissmann; C Haferlach; F Dicker; K Bayer; V Grossmann; T Alpermann; A Roller; A Kohlmann; T Haferlach; W Kern; S Schnittger
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

3.  Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.

Authors:  Stephan Stilgenbauer; Andrea Schnaiter; Peter Paschka; Thorsten Zenz; Marianna Rossi; Konstanze Döhner; Andreas Bühler; Sebastian Böttcher; Matthias Ritgen; Michael Kneba; Dirk Winkler; Eugen Tausch; Patrick Hoth; Jennifer Edelmann; Daniel Mertens; Lars Bullinger; Manuela Bergmann; Sabrina Kless; Silja Mack; Ulrich Jäger; Nancy Patten; Lin Wu; Michael K Wenger; Günter Fingerle-Rowson; Peter Lichter; Mario Cazzola; Clemens M Wendtner; Anna M Fink; Kirsten Fischer; Raymonde Busch; Michael Hallek; Hartmut Döhner
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

4.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Sara Monti; Carmela Ciardullo; Clara Deambrogi; Hossein Khiabanian; Roberto Serra; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Roberto Marasca; Michele Dal-Bo; Francesca Maria Rossi; Pietro Bulian; Josep Nomdedeu; Giovanni Del Poeta; Valter Gattei; Laura Pasqualucci; Raul Rabadan; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

5.  Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Valeria Spina; Riccardo Bomben; Silvia Rasi; Michele Dal-Bo; Alessio Bruscaggin; Francesca Maria Rossi; Sara Monti; Massimo Degan; Carmela Ciardullo; Roberto Serra; Antonella Zucchetto; Josep Nomdedeu; Pietro Bulian; Alberto Grossi; Francesco Zaja; Gabriele Pozzato; Luca Laurenti; Dimitar G Efremov; Francesco Di-Raimondo; Roberto Marasca; Francesco Forconi; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

Review 6.  Towards targeted therapy of chronic lymphocytic leukemia.

Authors:  Carsten U Niemann; Jade Jones; Adrian Wiestner
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

Review 8.  Implications of new prognostic markers in chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

9.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:  Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  N Engl J Med       Date:  2011-12-12       Impact factor: 91.245

10.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Authors:  Giulia Fabbri; Silvia Rasi; Davide Rossi; Vladimir Trifonov; Hossein Khiabanian; Jing Ma; Adina Grunn; Marco Fangazio; Daniela Capello; Sara Monti; Stefania Cresta; Ernesto Gargiulo; Francesco Forconi; Anna Guarini; Luca Arcaini; Marco Paulli; Luca Laurenti; Luigi M Larocca; Roberto Marasca; Valter Gattei; David Oscier; Francesco Bertoni; Charles G Mullighan; Robin Foá; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  J Exp Med       Date:  2011-06-13       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.